Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025. In the quarter to June 2026, revenue grew 6.48%, EPS fell 36.5%, free cash flow fell 14.2% and total debt rose 100.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

49.92 0.72 +1.46%
Market cap
$2.3B
P/E
13.9×
Fwd P/E
10.3×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
9.12% 10.22% 10.31% 11.29%

+8 more TTM periods

Piotroski F-Score
4 5 5 7
ROA
4.30% 5.52% 5.47% 5.94%
ROIC
4.70% 6.82% 7.15% 7.63%
Return on Tangible Assets
37.38% 44.03% 44.19% 46.07%
Average Days of Receivables
61.89 64.34 62.99 65.41
Free Cash Flow per Share
4.96 5.09 5.58 5.21
Free Cash Flow
235.36 246.45 267.19 255.45
Other line items

Show all line items

Columns are period end dates